Scalper1 News
Here’s a quick rundown of Monday’s after-the-close action: JetBlue Airways (JBLU) said Sept. traffic jumped 13.3% while capacity increased 13.1%. Load factor rose 0.2 percentage point to 81.1%. Shares were down 2.1% after the closing bell. Amgen (AMGN) issued positive trial data for its romosozumab, which showed increased estimated bone strength at the spine and hip in postmenopausal women with low bone mass. Shares edged up 0.5% late. Silicon Scalper1 News
Scalper1 News